Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission.
Blaise
D
D
Maraninchi
D
D
Michallet
M
M
Reiffers
J
J
Jouet
J P
JP
Milpied
N
N
Devergie
A
A
Attal
M
M
Sotto
J J
JJ
Kuentz
M
M
Ifrah
N
N
Dauriac
C
C
Bordigoni
P
P
Gratecos
N
N
Guilhot
F
F
Guyotat
D
D
Gluckman
E
E
Vernant
J P
JP
D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D019172:Transplantation Conditioning; D014916:Whole-Body Irradiation
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D002066:Busulfan